| Dr Kathryn Amanda Mcfarland, MD | |
|
8687 Hospital Dr Ste 102, Douglasville, GA 30134-5616 | |
| (678) 785-5001 | |
| (888) 464-0963 |
| Full Name | Dr Kathryn Amanda Mcfarland |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 26 Years |
| Location | 8687 Hospital Dr Ste 102, Douglasville, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134188493 | NPI | - | NPPES |
| 1134188493 | Other | GA | TRICARE |
| 003146792C | Medicaid | GA | |
| P01979634 | Other | GA | RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 200400715 (North Carolina) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 71820 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tanner Medical Center Villa Rica | Villa rica, GA | Hospital |
| Entity Name | Emory Specialty Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407864168 PECOS PAC ID: 3476559782 Enrollment ID: O20061010000447 |
News Archive
Scientists from RUDN University have synthesized a number of new cytotoxic substances - the ones that can damage cells. In the future the results of the study can be used in cancer therapy.
STRATAGEM COST Action (New diagnostic and therapeutic tools against multidrug resistant tumors) has created a "Task Force" of researchers contributing to Covid-19 research.
The Food and Drug Administration approved Vitrase (hyaluronidase for injection). Vitrase is an injectable drug approved as an adjunct to (in combination with) other injected drugs to increase their absorption and dispersion. Hyaluronidase has been used most commonly in combination with local anesthetics in the setting of ophthalmic (eye) surgery.
The National Institutes of Health has awarded two co-investigators at Albert Einstein College of Medicine a five-year, $2.6 million grant to make immunotherapy agents that more precisely and effectively treat a variety of cancers while causing far fewer side effects than current immunotherapies.
The Ministry of Health in Indonesia has confirmed an additional two cases of human infection with the H5N1 avian influenza virus.
› Verified 4 days ago
| Entity Name | Ctca Physicians Group Of Georgia, Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447520333 PECOS PAC ID: 4880841212 Enrollment ID: O20120820001117 |
News Archive
Scientists from RUDN University have synthesized a number of new cytotoxic substances - the ones that can damage cells. In the future the results of the study can be used in cancer therapy.
STRATAGEM COST Action (New diagnostic and therapeutic tools against multidrug resistant tumors) has created a "Task Force" of researchers contributing to Covid-19 research.
The Food and Drug Administration approved Vitrase (hyaluronidase for injection). Vitrase is an injectable drug approved as an adjunct to (in combination with) other injected drugs to increase their absorption and dispersion. Hyaluronidase has been used most commonly in combination with local anesthetics in the setting of ophthalmic (eye) surgery.
The National Institutes of Health has awarded two co-investigators at Albert Einstein College of Medicine a five-year, $2.6 million grant to make immunotherapy agents that more precisely and effectively treat a variety of cancers while causing far fewer side effects than current immunotherapies.
The Ministry of Health in Indonesia has confirmed an additional two cases of human infection with the H5N1 avian influenza virus.
› Verified 4 days ago
| Entity Name | Kingdom Cardiovascular Care And Wellness Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396491254 PECOS PAC ID: 5890164511 Enrollment ID: O20221219002347 |
News Archive
Scientists from RUDN University have synthesized a number of new cytotoxic substances - the ones that can damage cells. In the future the results of the study can be used in cancer therapy.
STRATAGEM COST Action (New diagnostic and therapeutic tools against multidrug resistant tumors) has created a "Task Force" of researchers contributing to Covid-19 research.
The Food and Drug Administration approved Vitrase (hyaluronidase for injection). Vitrase is an injectable drug approved as an adjunct to (in combination with) other injected drugs to increase their absorption and dispersion. Hyaluronidase has been used most commonly in combination with local anesthetics in the setting of ophthalmic (eye) surgery.
The National Institutes of Health has awarded two co-investigators at Albert Einstein College of Medicine a five-year, $2.6 million grant to make immunotherapy agents that more precisely and effectively treat a variety of cancers while causing far fewer side effects than current immunotherapies.
The Ministry of Health in Indonesia has confirmed an additional two cases of human infection with the H5N1 avian influenza virus.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kathryn Amanda Mcfarland, MD 8687 Hospital Dr Ste 102, Douglasville, GA 30134-5616 Ph: (678) 785-5001 | Dr Kathryn Amanda Mcfarland, MD 8687 Hospital Dr Ste 102, Douglasville, GA 30134-5616 Ph: (678) 785-5001 |
News Archive
Scientists from RUDN University have synthesized a number of new cytotoxic substances - the ones that can damage cells. In the future the results of the study can be used in cancer therapy.
STRATAGEM COST Action (New diagnostic and therapeutic tools against multidrug resistant tumors) has created a "Task Force" of researchers contributing to Covid-19 research.
The Food and Drug Administration approved Vitrase (hyaluronidase for injection). Vitrase is an injectable drug approved as an adjunct to (in combination with) other injected drugs to increase their absorption and dispersion. Hyaluronidase has been used most commonly in combination with local anesthetics in the setting of ophthalmic (eye) surgery.
The National Institutes of Health has awarded two co-investigators at Albert Einstein College of Medicine a five-year, $2.6 million grant to make immunotherapy agents that more precisely and effectively treat a variety of cancers while causing far fewer side effects than current immunotherapies.
The Ministry of Health in Indonesia has confirmed an additional two cases of human infection with the H5N1 avian influenza virus.
› Verified 4 days ago
Safal Shetty, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6001 Professional Pkwy Ste 2020, Douglasville, GA 30134 Phone: 770-422-1372 | |
Michael B Piansky, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6043 Prestley Mill Rd Ste B, Douglasville, GA 30134 Phone: 770-941-8100 Fax: 678-945-9331 | |
Navinchandra M Ruparelia, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4904 Timber Ridge Dr, Suite 202a, Douglasville, GA 30135 Phone: 770-949-6548 Fax: 770-949-9561 | |
Dr. Gray Akoegbe, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6001 Professional Pkwy Ste 2080, Douglasville, GA 30134 Phone: 678-715-5080 | |
Neal K Osborn, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8855 Hospital Dr, Suite 101, Douglasville, GA 30134 Phone: 678-784-5020 Fax: 678-784-5024 | |
Dr. Nana Abena Arthur, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8954 Hosptial Drive, Wellstar Health System Douglas Hospital, Douglasville, GA 30134 Phone: 678-838-2585 |